NCT05942508 2023-07-12A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and ChemotherapyShandong Cancer Hospital and InstitutePhase 1 Unknown20 enrolled